Immediate Impact
24 standout
Citing Papers
2023 FDA TIDES (Peptides and Oligonucleotides) Harvest
2024 Standout
Digital Transformation in Healthcare: Technology Acceptance and Its Applications
2023 Standout
Works of Gabriel Schembri being referenced
Randomized controlled trial of the tolerability and completion of maraviroc compared with Kaletra® in combination with Truvada® for HIV post-exposure prophylaxis (MiPEP Trial)
2017
The Internet as a diagnostic aid: the patients' perspective
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Gabriel Schembri | 48 | 61 | 24 | 46 | 19 | 140 | |
| M Gale-Rowe | 26 | 63 | 22 | 94 | 21 | 156 | |
| Margaret Camarca | 40 | 113 | 35 | 85 | 11 | 201 | |
| Colin Fitzpatrick | 16 | 98 | 11 | 50 | 27 | 159 | |
| I. Alcaraz | 96 | 67 | 16 | 96 | 25 | 235 | |
| Tobias Vickers | 18 | 56 | 22 | 81 | 15 | 126 | |
| Jullapong Achalapong | 55 | 126 | 42 | 78 | 21 | 232 | |
| Andrés Marco | 21 | 117 | 17 | 175 | 16 | 235 | |
| Nicole Simmons | 15 | 97 | 31 | 72 | 13 | 181 | |
| Richard E. Haaland | 52 | 172 | 23 | 98 | 23 | 239 | |
| Nicolas Méda | 8 | 88 | 23 | 85 | 16 | 159 |
All Works
Loading papers...